Henry Schein marked a -3.8% change today, compared to 2.0% for the S&P 500. Is it a good value at today's price of $61.66? Only an in-depth analysis can answer that question, but here are some facts that can give you an idea:
-
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.
-
Henry Schein belongs to the Health Care sector, which has an average price to earnings (P/E) ratio of 24.45 and an average price to book (P/B) of 4.16
-
The company's P/B ratio is 2.26
-
Henry Schein has a trailing 12 month Price to Earnings (P/E) ratio of 18.0 based on its trailing 12 month price to earnings (EPS) of $3.42 per share
-
Its forward P/E ratio is 10.8, based on its forward earnings per share (EPS) of $5.7
-
HSIC has a Price to Earnings Growth (PEG) ratio of 1.54, which shows the company has a fair value when we factor growth into the price to earnings calculus.
-
Over the last four years, Henry Schein has averaged free cash flows of $596.11 Million, which on average grew -2.3%
-
HSIC's gross profit margins have averaged 28.7 % over the last four years and during this time they had a growth rate of 5.6 % and a coefficient of variability of 67.1 %.
-
Henry Schein has moved -13.0% over the last year compared to 17.0% for the S&P 500 -- a difference of -30.0%
-
HSIC has an average analyst rating of hold and is -24.47% away from its mean target price of $81.64 per share